Key Laboratory of Etiology and Biosafety for Emerging and Highly Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences (Laboratory Code: 2014DP173064) was approved to establish recently.

The laboratory is dedicated to advancing the public health and the national security through innovative research on etiology and biosafety for emerging and highly infectious diseases (EID). As part of Center for Emerging Infectious Diseases, CAS, the laboratory has thirteen research groups specialized in different fields of EID, such as rapid detection, molecular epidemiology and early warning,pathogenic mechanism, prevention and control strategies (therapeutic antibody, vaccine, and drug development and assessment), and biosafety & biosecurity.

Based on WIV's high-level biosafety platform, the establishment of this laboratory will further demonstrate CAS's global influence on emerging infectious diseases, highly infectious pathogen, and high-level biosafety. Complying with the requirements of CAS's key laboratory, this laboratory will strive to be the authoritative research base for China's emerging and highly infectious pathogenic microorganism and a high-tech hub, laying a theoretical and technological foundation for the prevention, control, diagnosis, and treatment of China's emerging and highly infectious pathogen.